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I INTRODUCTION 
A neck mass in an adult, when present for longer than a week is 
pathological until proven otherwise. Enlarged lymph nodes are by far 
the most common neck masses encountered. In our country, tubercular 
lymphadenitis is not uncommon but even so, a large percentage of all 
persistent adult neck masses in adults turn out to be malignant.  
Lymphadenopathy is one of the first sign of malignancy in a 
patient. FNAC not only confirms the presence of metastatic disease, but 
also gives clues regarding the nature and origin of the primary tumour. 
The number of lymph nodes involved, the size of the lymph nodes or the 
lymph node metastasis, or the regional lymph node basin involved also 
has been shown to have prognostic value. In patients with enlarged 
lymph nodes and previously documented malignancy, FNAC can 
obviate further surgery performed merely to confirm the presence of 
metastasis. However, regional lymphadenopathy is not always due to 
metastatic tumour, and not every nodule represents a lymph node. Cysts 
(congenital or acquired), abscesses, subcutaneous benign and malignant 
tumours may also raise the question of lymph node metastasis, 
especially in patients with a known tumour. 
A positive evidence of tuberculosis can obviate the need for further 
evaluation and leads to early instillation of definite therapy at the 
  
secondary or primary care centre itself. Early treatment leads to better 
prognosis, as organism load and virulence are minimal; with a good host 
response. The disease spread and community burden are significantly 
reduced. 
Avoiding false-positive diagnosis is of obvious importance since 
therapeutic and surgical decisions are taken on cytology results.  
Moreover; the procedure is very simple, cost effective, and free 
from complications, well tolerated by the patient, can be done on an out-
patient basis and repeatable when necessary. 
India is imminently suited to use this procedure. 
This study will address the neck nodes occurring in the adult 
population. They are usually metastatic nodes, lymphomas or 
tuberculosis. The metastatic are generally from the upper aero digestive 
tract, thyroid and salivary glands or may present as occult primaries. 
Occasionally a neck metastasis from a distant site springs from the 
gastrointestinal tract, kidney or the lung. Other primary sites below the 
clavicle, which may appear in the neck, are the cervix, ovary, testis and 
sometimes even the bladder. 
 
 
  
 
II Aims and Objectives 
 To study the pattern of cervical lymph node enlargement.  
 To evaluate the diagnostic accuracy of FNAC in cervical 
lymphadenopathy with an emphasis on discordant cases between the 
cytology and the histopathology 
 
 
 
 
 
 
 
 
 
 
 
  
 
III REVIEW OF LITERATURE 
HISTORY 
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1705 
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Proposed classifications of neck dissections 
 
 
 
 
  
EMBRYOLOGY 
During the 5th week of gestation, two paired and two unpaired 
endothelial sacs arise as outgrowths from the venous channels. These sacs 
form the primordia of the lymphatic system.  
The first primordial lymph sacs to appear are the paired jugular 
sacs in the neck. They are located bilaterally at the junction of the 
subclavian and internal jugular (precardinal) veins. Soon thereafter, 
extensions from these sacs are visible in the upper limbs. The next sac to 
appear is unpaired and located at the mesenteric root in the retroperitoneal 
space. Later the unpaired cisterna chyli develops dorsal to the mesenteric 
sac. The final paired sacs, two posterior (iliac) sacs, appear at the junction 
of the sciatic and femoral veins. In short, it may be said that 
embryologically the lymph system originates and terminates in the 
venous system. 
 
  
By the end of the ninth week, these six lymphatic sacs are linked 
together by multiple endothelial channels to form a complicated network 
of lymphatic vessels. During early fetal development mesenchymal cells 
invade these sacs, converting them into groups of lymph nodes. True 
lymph nodes, however, do not appear until the system of vessels is well 
established.  
The earliest nodes appear in the places occupied by the primary 
sacs and confluences of capillary plexuses. At first, the nodes are 
represented by unencapsulated lymphoid tissue located within the 
meshwork of lymphatic channels. Later, the lymphoid mass separates into 
smaller portions allowing the inward growth of blood vessels and the 
lymphatic network. Each mass, together with portions of the surrounding 
network, becomes enclosed by a capsule of connective tissue. Original 
lymphoid tissue transforms into the medullary cords and cortical nodules 
of the node; the enclosed lymphatic capillaries form the peripheral lymph 
sinus. Cervical lymph nodes appear around the 9th week. Later, several 
other groups of lymph nodes are formed in various areas of the body. 
HISTOLOGY 
Nodes vary greatly in size, ranging from 1-2 mm to 3-4 cm in 
diameter. Each node is covered by a capsule of dense connective tissue 
  
which sends trabecular extensions to the centre of the lymph node. The 
nodal parenchyma is divided into two regions: cortex and medulla. 
The cortex is the outer and more densely staining part of the lymph 
node. The cortex contains lymph nodules or follicles (aggregations of 
lymphocytes) which contain lighter staining germinal centres. According 
to Roth and Reith, the germinal centre is a "morphological indication of 
lymphatic tissue response which ultimately leads to lymphocyte, plasma 
cell, and antibody formation." The germinal centre may be the site of 
genesis of the immune system.  
The innermost part of the lymph node is the medulla. The 
lymphoid tissue of the medulla is organized into medullary cords and 
medullary sinuses. The medullary cords consist of reticular fibres and 
cells that develop around tiny blood vessels. Accordingly, small 
lymphocytes, macrophages, and mature plasma cells can be found in 
association with medullary cords. The medullary sinuses converge in the 
vicinity of efferent lymphatic vessels and serve to drain the lymph node. 
Stellate cells found within the sinuses form a web like series of 
microscopic baffles, allowing interaction with macrophages in the wall of 
the sinus. This interaction may create a trap for cells passing through the 
lumen of the sinus.  
  
Lymph capillaries are very thin. They unite to form lymphatic 
vessels. Lymph capillaries are lined by endothelium and are slightly 
larger than blood capillaries. They are unique, however, in that they lack 
a continuous basal lamina and are permeable only in one direction. The 
edges of adjacent endothelial cells overlap significantly, providing an 
intercellular cleft with one or two tiny points of closer apposition and 
adherence. 
Extracellular bundles of filaments extend outward from the 
endothelium between collagen bundles of the surrounding connective 
tissues. These bundles are believed to play a role in keeping the lumen of 
the vessel open. Furthermore, it is presumed that as interstitial fluid 
increases around the lymphatic capillary, the "anchoring" filaments open 
the clefts, allowing the inward flow of intercellular fluid and even large 
molecules. As a result, relatively large products of metabolism can enter 
the lymph vessel, thereafter being pushed by the contraction of 
surrounding muscles and interstitial pressures. 
The pathway of lymph starts in interstitial tissue spaces where 
lymph accumulates, perhaps secondary to the slight predominance of 
capillary filtration and reabsorption. Lymph passes from lymph 
capillaries to lymphatic vessels by propulsion and contraction. The 
lymphatic vessels carry the fluid to the lymph nodes by way of the nodal 
  
sinuses. Efferent vessels carry the lymph to the next node in the chain, 
and eventually the fluid flows to lymph trunks. The trunks pass the lymph 
into the thoracic and right lymphatic duct, where it reaches the venous 
circulation. 
If some lymph vessels are damaged or blocked, new vessels form 
readily. The system drains broadly into the venous system. It is well 
understood that the thoracic duct and the right lymphatic duct open into 
their respective brachiocephalic veins, but those who have studied these 
vessels report openings of lymph vessels into the inferior vena cava, 
renal, suprarenal, azygos, and iliac veins. 
Lymph capillaries and lymphatic vessels have one-way valves 
which open upon contraction of the vascular wall. These valves permit 
the passage and circulation of lymph fluid (3 to 5 liters daily) into larger 
vessels and, ultimately, to the thoracic ducts. The valves are bicuspid and 
prevent backflow.  
Lymphatic vessels always follow minute arteries and veins. They 
resemble veins in structure but have thinner walls, more valves, and 
contain lymph nodes at various intervals along their length.  
  
 
PHYSIOLOGY 
The lymph nodes are responsible for filtering lymph and producing 
antibodies by responding to antigens. 
The lymphatic and blood vascular systems are fellow travellers, 
with multiple interactions in health and disease. There are two principal 
pathways by which malignant cells spread via the lymphatic system: 
  Permeation of minute lymphatic vessels, which ultimately leads to 
growth and spread to regional lymph nodes 
 Lymphatic metastasis by tumor cell emboli, which may bypass a 
lymph node or become entrapped in the lymph node 
  
The lymph nodes may act as temporary filters, in which metastatic 
malignant cells are trapped, propelled into vessels, or destroyed. 
It is known that lymph nodes can effectively arrest the passage of 
particulate matter and blood cells, and entrap and destroy bacteria. Some 
viruses, however, can proliferate rapidly within the lymph node and 
thereafter easily disseminate throughout the body. Similarly, lymph nodes 
may fail to entrap other kinds of cells carried in the lymph. For example, 
a large percentage of cancer cells may transit in lymphatic vessels 
without being arrested at the node. 
When malignant cells are entrapped within the node they may 
proliferate rapidly, greatly increasing the size of the node. Non-tender, 
hard, compacted masses of nodes usually contain metastatic carcinoma or 
very aggressive intrinsic neoplasms. The particular location of the lymph 
gland enlargement often provides very definite clues to the origin of the 
primary lesion. 
 
ANATOMY 
There are a total of 800 lymph nodes in the body, 300 of which are 
located in the head and neck region. The cervical lymphatic system 
consists of interconnected groups or chains of nodes that parallel the 
  
major neurovascular structures in the head and neck. All the structures in 
the head and neck have specific and predictable draining nodes associated 
with them. 
TRIANGLES OF NECK 
The sternocleidomastoid muscle divides each side of the neck into 2 
major triangles: 
1. Anterior triangle 
– Digastric triangle  
– Submental triangle 
– Carotid triangle 
– Muscular triangle 
2. Posterior triangle  
– Occipital triangle 
– Supraclavicular triangle 
 
  
DIGASTRIC TRIANGLE  
     The digastric triangle is bordered above by the base of the mandible 
and its projection to the mastoid process, posteroinferiorly by the 
posterior belly of digastric and by stylohyoid, and anteroinferiorly by the 
anterior belly of digastric. It is covered by the skin, superficial fascia, 
platysma and deep fascia, which contain branches of the facial and 
transverse cutaneous cervical nerves. Its floor is formed by mylohyoid 
and hyoglossus. The anterior region of the digastric triangle contains the 
submandibular gland, which has the facial vein superficial to it and the 
facial artery deep to it. The submental and mylohyoid arteries and nerves 
lie on mylohyoid. The submandibular lymph nodes are variably related to 
the submandibular gland.  
 
SUBMENTAL TRIANGLE  
    The single submental triangle is demarcated by the anterior bellies of 
both the digastric muscles. The apex is formed by the chin. Base is 
formed by the body of the hyoid bone and the floor by both the 
mylohyoid muscles. It contains lymph nodes and small veins which unite 
to form the anterior jugular vein. 
 
MUSCULAR TRIANGLE  
  
    The muscular triangle is bounded anteriorly by the mid line of the neck 
from the hyoid bone to the sternum, inferoposteriorly by the anterior 
margin of sternocleidomastoid muscle and posterosuperiorly by the 
superior belly of omohyoid muscle. The triangle contains sternohyoid, 
omohyoid, sternothyroid and thyrohyoid.  
 
CAROTID TRIANGLE  
       The carotid triangle is limited posteriorly by sternocleidomastoid 
muscle, anteroinferiorly by the superior belly of omohyoid muscle and 
superiorly by stylohyoid  muscle and the posterior belly of digastric 
muscle. The hyoid bone forms its anterior angle and adjacent floor and 
can be located on simple inspection, verified by palpation. Parts of 
thyrohyoid, hyoglossus and inferior and middle pharyngeal constrictor 
muscles form its floor. The carotid triangle contains the upper part of the 
common carotid artery and its division into external and internal carotid 
arteries. Overlapped by the anterior margin of sternocleidomastoid, the 
external carotid artery is first anteromedial, then anterior to the internal 
carotid artery. Branches of the external carotid artery are encountered in 
the carotid triangle. Thus the superior thyroid artery runs anteroinferiorly, 
the lingual artery anteriorly with a characteristic upward loop, the facial 
artery anterosuperiorly, the occipital artery posterosuperiorly and the 
  
ascending pharyngeal artery medial to the internal carotid artery. Arterial 
pulsation greets the examining finger. The superior thyroid, facial, 
lingual, ascending pharyngeal and sometimes the occipital, veins, 
correspond to the branches of the external carotid artery, and all drain into 
the internal jugular vein. The hypoglossal nerve crosses the external and 
internal carotid arteries. It curves round the origin of the lower 
sternocleidomastoid branch of the occipital artery, and at this point the 
superior root of the ansa cervicalis leaves it to descend anteriorly in the 
carotid sheath. The internal laryngeal nerve and, below it, the external 
laryngeal nerve, lie medial to the external carotid artery below the hyoid 
bone. Many structures in this region, such as all or part of the internal 
jugular vein, associated deep cervical lymph nodes, and the vagus nerve, 
may be variably obscured by sternocleidomastoid.  
 
POSTERIOR TRIANGLE OF THE NECK  
         The posterior triangle is delimited anteriorly by sternocleidomastoid, 
posteriorly by the anterior edge of trapezius, and inferiorly by the middle 
third of the clavicle. The apex is formed by the attachments of 
sternocleidomastoid and trapezius to the occiput and is often blunted. The 
roof of the posterior triangle is formed by the investing layer of the deep 
cervical fascia. The floor of the triangle is formed by the prevertebral fascia 
  
overlying splenius capitis, levator scapulae and the scalene muscles. It is 
crossed, 1inch above the clavicle, by the inferior belly of omohyoid muscle, 
which subdivides it into occipital and supraclavicular triangles. Collectively 
these contain the cervical and brachial plexuses, the subclavian artery and 
the spinal accessory nerve. The spinal accessory nerve pierces 
sternocleidomastoid and crosses levator scapulae obliquely downwards and 
backwards to reach the deep surface of trapezius. The muscles forming the 
floor of the posterior triangle constitute the anterior and lateral groups of the 
prevertebral musculature. Lymph nodes lie along the posterior border of 
sternocleidomastoid from the mastoid process to the root of the neck  
The regional lymphatic drainage of the neck is divided into seven 
levels.  
The system developed by Memorial Sloan-Kettering Cancer Centre, is 
ease and creates uniformity in describing regional nodal involvement in 
cancer of the head and neck. These levels allow for a standardized format 
for radiologists, surgeons, pathologists, and radiation oncologists to 
communicate concerning specific sites within the neck and does not 
represent regions isolated by fascial planes.  
The levels are defined as the following: 
 
Level I—the submental and submandibular nodes 
 
Level Ia—the submental nodes; medial to the anterior belly 
  
of the digastric muscle bilaterally, symphysis of mandible 
superiorly, and hyoid inferiorly 
 Level Ib—the submandibular nodes and gland; posterior to the anterior 
belly of digastric, anterior to the posterior belly of digastric and inferior 
to the body of the mandible 
 
Level II—upper jugular chain nodes 
 
Level IIa—jugulodigastric nodes; deep to 
sternocleidomastoid (SCM) muscle, anterior to the posterior 
border of the muscle, posterior to the posterior aspect of the 
posterior belly of digastric, superior to the level of the 
hyoid, inferior to spinal accessory nerve (CN XI) 
 
Level IIb—submuscular recess; superior to spinal accessory 
nerve to the level of the skull base 
 
Level III—middle jugular chain nodes; inferior to the 
hyoid, superior to the level of the hyoid, deep to SCM from 
posterior border of the muscle to the strap muscles medially 
 
Level IV—lower jugular chain nodes; inferior to the level of 
the cricoid, superior to the clavicle, deep to SCM from 
posterior border of the muscle to the strap muscles medially 
 
Level V—posterior triangle nodes 
 
Level Va—lateral to the posterior aspect of the SCM, 
inferior and medial to splenius capitis and trapezius, 
  
superior to the spinal accessory nerve 
 
Level Vb—lateral to the posterior aspect of SCM, medial to 
trapezius, inferior to the spinal accessory nerve, superior to 
the clavicle 
 
Level VI—anterior compartment nodes; inferior to the 
hyoid, superior to suprasternal notch, medial to the lateral 
extent of the strap muscles bilaterally 
 
Level VII—paratracheal nodes; inferior to the suprasternal 
notch in the upper mediastinum 
 
 
 
Level IA: Submental Nodes 
These are lymph nodes located within the triangular boundary of 
the anterior belly of the two digastric muscles and the hyoid bone. 
  
Cancers arising from anterior tongue, the floor of the mouth, anterior 
mandibular alveolar ridge and lower lip metastasise to these nodes. 
Level IB: Submandibular Nodes 
These are lymph nodes located within the boundaries of the 
anterior and posterior bellies of the digastric muscles, and the body of the 
mandible. Radiographically, the vertical plane at the posterior aspect of 
the submandibular gland demarcates the posterior aspect of level IB from 
level IIA. The group includes the pre- and post-glandular nodes, and the 
pre- and post-vascular nodes. 
The submandibular gland is excised en block when the lymph 
nodes within this triangle are resected. Cancers arising from the soft 
tissue structures of the mid face, oral cavity, anterior nasal cavity, and 
submandibular gland metastasise to these nodes. 
. 
Levels II:  Upper Jugular Nodes 
These are lymph nodes located along the upper third of the internal 
jugular vein and adjacent to spinal accessory nerve extending from the 
the skull base (above) to the inferior border of the hyoid bone (below). 
The medial (anterior) boundary is the lateral border of the stylohyoid 
muscle and the sternohyoid muscle. Radiologically, posterior aspect of 
the submandibular gland is the anterior limit. The lateral (posterior) 
boundary is the posterior border of the sternocleidomastoid muscle. The 
  
malignancies from oral cavity, oropharynx, nasal cavity, nasopharynx, 
larynx,  hypopharynx and the parotid gland metastases to level II nodes. 
The spinal accessory nerve divides the level into a sublevel IIA located 
medial (anterior) and sublevel IIB nodes located posterior (lateral). In 
case of oral cavity, larynx and hypopharynx cancers if level IIa is not 
involved it may not be necessary to dissect IIb nodes. 
Level III: Middle Jugular Nodes 
These are lymph nodes located around the middle third of the 
internal jugular vein. They extend from the inferior border of the hyoid 
bone above, to the inferior border of the cricoid cartilage below. The 
medial (anterior) boundary is the lateral border of the sternohyoid muscle, 
and the lateral (posterior) boundary is the posterior border of the 
sternocleidomastoid muscle. Malignancies arising from the  nasopharynx, 
oral cavity, oropharynx, hypo pharynx, and larynx metastases to these 
nodes. This group includes the jugulo-omohyoid node, which lies just 
above the superior belly of the omohyoid muscle when it crosses the 
internal jugular vein. 
Level IV: Lower Jugular Nodes 
These are lymph nodes located around the lower third of the 
internal jugular vein. They extend from the inferior border of the cricoid 
cartilage above, to the clavicle below. The medial (anterior) boundary is 
the lateral border of the sternohyoid muscle. The posterior border of the 
  
sternocleidomastoid muscle is the posterior boundary. These nodes have 
high risk of harbouring metastases from malignancies arising from the, 
cervical oesophagus, hypopharynx, and larynx. Metastasis in Level IVa 
nodes has increased risk of secondaries in Level VI and Level IVb nodes 
increases risk in Level V. The Virchow’s node is located in Level IV. 
 
Levels VA & VB: Posterior Triangle Nodes  
These are lymph nodes predominantly located along the lower half 
of the spinal accessory nerve and the transverse cervical artery. 
Superiorly, apex is formed by the convergence of the sternocleidomastoid 
and the trapezius muscles. Clavicle forms the inferior boundary. The 
medial (anterior) boundary is the posterior border of the 
sternocleidomastoid muscle. The lateral (posterior) boundary is formed 
by the anterior border of the trapezius muscle. The supraclavicular nodes 
are also included in the posterior triangle group. A horizontal plane along 
the inferior border of the arch of the cricoid cartilage separates Sublevel 
VA from Sublevel VB.  
Sublevel VA harbour metastases from cancers of nasopharynx and 
oropharynx. Thyroid gland cancers metastasise to sublevel VB. 
 Level VI: Anterior (Central) Compartment Nodes 
Level VI lymph nodes include the precricoid (Delphian) node, the 
pre- and paratracheal nodes, and the perithyroidal nodes, including the 
  
lymph nodes along the recurrent laryngeal nerves. They are bound 
superiorly by the hyoid bone, inferiorly by the suprasternal notch. The 
common carotid arteries on both sides form the lateral borders. Cancers 
arising from the thyroid gland, piriform sinus, subglottic larynx, and 
cervical oesophagus metastasise to level VI. 
 
METASTATIC LYMPH NODES 
An enlarged cervical lymph node is often the first clinical 
manifestation of head and neck cancers. Cervical lymphadenopathy is the 
presenting symptom in 47% of patients with cancer of the nasopharynx, 
25% of patients with cancer of the oral cavity and oropharynx, and 23% 
of the patients with thyroid cancer. The primary tumour may not be 
detectable in some cases.  
Painless swelling is the usual presentation. In late stages patient 
may complain of pain due to involvement of nerves and surrounding 
structures. Associated symptoms of primary are usually present. 
 The precise location of the gland can give clue to the site of 
primary tumour. Upper deep cervical nodes are involved when the 
primary lies in head, face and interior of the mouth. The middle and 
lower deep cervical nodes are involved when the primary is in the larynx 
or thyroid. Supraclavicular lymph node enlargement indicates thoracic or 
  
abdominal disease. When Virchow’s glands are enlarged it is called 
Troisier’s sign.  
The lymph nodes are irregular in shape and of varying sizes. The 
nodes are usually hard to feel. As the nodes are tethered their mobility 
becomes restricted. In early stage the nodes can be moved sidewards but 
not vertically. Later on nodes become absolutely fixed to the surrounding 
structures. Gradually the skin may be involved and is pulled towards the 
mass.  
When the primary growth is not detected, the secondarily involved 
lymph node should be excised. When the primary growth is operable, the 
primary growth is adequately excised along with excision of the involved 
nodes. Excisions are always a form of neck dissections. 
 
Staging of the Neck Nodes 
• NX - Regional lymph nodes cannot be assessed 
• N0  - No regional lymph node metastasis 
• N1  - Metastasis in a single ipsilateral lymph node, 3 cm or less in 
greatest dimension 
• N2 - Metastasis in a single ipsilateral lymph node, more than 
3 cm but not more than 6 cm in greatest dimension; or in multiple 
ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in 
  
bilateral or contralateral lymph nodes, none more than 6 cm in greatest 
dimension 
o N2a -  Metastasis in single ipsilateral lymph node more than 
3 cm but not more than 6 cm in greatest dimension 
o N2b -  Metastasis in multiple ipsilateral lymph nodes, none 
more than 6 cm in greatest dimension 
o N2c -  Metastasis in bilateral or contralateral lymph nodes, 
none more than 6 cm in greatest dimension 
• N3 -  Metastasis in a lymph node more than 6 cm in greatest 
dimension 
 
THE LYMPHOMAS 
Hodgkin's Disease 
Hodgkin’s disease is characterized by the presence of 
multinucleated Reed-Sternberg (RS) cells or one of their variants. As 
opposed to Non-Hodgkin’s Lymphoma, in which a monoclonal 
population of malignant lymphocytes usually predominates, in Hodgkin’s 
disease the malignant cells are a minority population outnumbered by 
inflammatory cells. 
Patients with Hodgkin’s disease typically present with non-tender 
lymphadenopathy. The cervical nodes are most commonly involved; 
  
other regions, which include the axillary, inguinal, mediastinal, and 
retroperitoneal nodes are less frequently affected at presentation. The 
presence or absence of B symptoms should be elucidated from the 
patient's history. B symptoms include any one of the following: 
unexplained fever with temperature over 38°C, night sweats significant 
enough to require changing bed clothes, or weight loss of more than 10% 
of body weight over 6 months. Although classic for Hodgkin’s disease, 
the Pel-Ebstein fever, with progressively shortening intervals between 
fevers, is a relatively rare phenomenon. 
The physical examination should include an evaluation of all 
lymph node bearing areas, including Waldeyer's tonsillar ring, and 
palpation for liver or splenic enlargement. Initial workup should include a 
complete blood cell count with a differential count, liver function tests, 
and a chest radiograph. A bone marrow biopsy is useful to determine the 
extent of the disease. Excisional biopsy of the largest node that is likely to 
provide the diagnosis should be performed. Careful selection of the 
biopsy site is important because some areas, particularly the inguinal 
region, frequently contain non diagnostic inflammatory nodes. 
  
 
Ann Arbor staging system for Hodgkin's disease 
  
Stage Criteria 
I Involvement of a single lymph node region (I) or a single 
extralymphatic organ or site (IE) 
II Involvement of two or more lymph node regions on the same side 
of the diaphragm (II) or of an extralymphatic organ and its 
adjoining lymph node site (IIE) 
III Involvement of lymph node sites on both sides of the diaphragm 
(III) or localized involvement of an extra-lymphatic site (IIIE), 
spleen (IIIS), or both (IIISE) 
IV Diffuse or disseminated involvement of one or more extralymphatic 
organs with or without associated lymph node involvement 
A Asymptomatic 
B Fever, night sweats, or weight loss of more than 10% 
 
Other clinical staging tools include computed tomography (CT), 
nuclear medicine scans, and bipedal lymphangiography. CT is used to 
detect mediastinal and abdominal lymphatic enlargement; however, nodes 
containing Hodgkin’s disease often are not enlarged. Gallium scans have 
been useful in detecting residual disease. The prognosis of patients with 
Hodgkin’s disease depends on the histologic subtype and stage of disease 
at presentation. The Rye modification of the Lukes-Butler classification 
of Hodgkin’s disease identifies four histologic subtypes: lymphocyte 
predominant, nodular sclerosis, mixed cellularity, and lymphocyte 
  
depleted. These subtypes are determined by the specific variant of Reed 
Sternberg cell, the ratio of these cells to the normal population, and the 
degree of sclerosis. 
The Ann Arbor staging system is used for staging Hodgkin’s 
disease based on the extent of disease. Clinical staging includes all data 
from the history and physical examination and nonoperative diagnostic 
studies. The Ann Arbor stages are subclassified to reflect lymphatic 
disease and involvement of extranodal areas designated by E, for 
involvement of an extralymphatic site (i.e., stomach or small intestine), or 
S, for splenic involvement. Disease is further subclassified according to 
the presence or absence of systemic symptoms of the disease. 
Increasing knowledge of the effect of patient characteristics, 
histologic subtype, and stage of disease have allowed more individualized 
treatment of patients, with dramatic improvements in survival. Staging 
laparotomy was first introduced to define disease extent in all 
presentations of Hodgkin’s disease. Subsequently, investigators 
performed staging by laparotomy to determine which patients had early 
stage disease that could be treated by local irradiation and which had 
extensive disease requiring systemic therapy. Both improvements in the 
accuracy of radiologic diagnostic procedures and more intensive use of 
chemotherapeutic and radiation treatments earlier in the course of the 
  
disease have decreased the number of patients who require staging 
laparotomy. 
Non-Hodgkin's Lymphoma 
 
Most patients with Non-Hodgkin’s Lymphoma present with 
superficial adenopathy, most commonly in the cervical lymph nodes. 
These nodes are generally enlarged and not tender. The Ann Arbor 
system is used to stage these patients, but it is less helpful in Non-
Hodgkin’s Lymphoma than in Hodgkin’s disease because more than half 
of Non-Hodgkin’s Lymphoma patients present with stage III or IV 
disease and approximately 20% present with B symptoms. Patients with 
Non-Hodgkin’s Lymphoma also are more likely to have hematogenous 
spread versus lymphatic spread as seen in patients with Hodgkin’s 
disease. 
Non-Hodgkin’s Lymphomas do not spread in the orderly manner 
that Hodgkin’s lymphoma does. 
Patients with Non-Hodgkin’s Lymphoma characteristically have a 
monoclonal proliferation of lymphocytes, with 80% of cases being of B-
cell derivation and the remainder originating from T cells. The diagnosis 
of various subsets of B-cell Non-Hodgkin’s Lymphoma depends on the 
identification of histopathologic markers using monoclonal antibodies 
and on cellular morphology; criteria assessed are a diffuse versus 
  
follicular (nodular) pattern of lymph node involvement, small versus 
large cell type, and cleaved versus noncleaved nuclear morphology. With 
this information, the lymphoma can be categorized according to the 
Working Formulation, which is a modification of the Lukes and Collins 
schema. The Working Formulation has simplified our understanding of 
the behaviours of these subtypes by placing them into one of three 
categories, depending on whether patients have a low, intermediate, or 
high risk of death due to the disease. The T-cell Non-Hodgkin’s 
Lymphomas are much more difficult to identify precisely and to place 
into prognostic groups. More recently, the proposed European-American 
classification of lymphoid neoplasms uses morphology, phenotype, and 
cytogenetics to classify these disorders 
 
Diagnostic Biopsy for Lymphoma 
When lymphoma is suspected, proper planning and execution of 
the biopsy are crucial to enable the pathologist to make a diagnosis. 
Because preservation of the architecture aids in histologic diagnosis, 
efforts should be made to avoid traction or cautery. The largest node 
found on physical examination should be biopsied. If several nodal areas 
are enlarged, biopsy of the cervical area is preferred to biopsy of an 
axillary node, which in turn is superior to biopsy of nodes from the 
inguinal region. In suspected extranodal disease or in the case of matted 
  
nodes, it is important to excise as generous an amount of tissue as 
possible. Communication with the pathologist is important to guarantee 
that adequate tissue is sent and that it is delivered in an acceptable 
fashion. In general, the specimen is sent fresh, is sent in saline, or is 
wrapped in a saline-soaked sponge. It is important that the specimen be 
sent directly to the pathologist and that there is an indication that the 
diagnosis of lymphoma is suspected. Needle biopsies rarely provide an 
adequate amount of tissue, although they may be helpful in ruling out a 
carcinoma or sarcoma or in suspected relapse of lymphoma when a tissue 
diagnosis is needed before treatment. 
 
TUBERCULOSIS 
Tuberculous lymphadenitis is a chronic granulomatous 
inflammation with caseating necrosis of the lymph nodes. In majority 
of cases human tubercle bacilli enter the body through the tonsil of the 
corresponding side. From there they move to the cervical nodes, so the 
upper deep cervical nodes are the most common to be involved. There 
is no generalised infection, so the cervical nodes involvement is not 
secondary to tuberculosis anywhere in the body.  
  
It may affect any age but commonly affects young adults. The 
incidence has diminished since introduction of BCG vaccine. The 
cervical nodes are the most common affected nodes.  
In tuberculosis, the lymph nodes on section show opaque and 
yellowish areas, which is the result of necrosis and caseation. 
Microscopically the characteristic feature is the tuberculous 
granuloma containing multinucleated giant cells (Langhans cells), 
surrounded by aggregation of epithelioid cells, activated T cell 
lymphocytes and fibroblasts.  
Stages of Tubercular Lymphadenitis 
1- Stage of Lymphadenitis 
Common in young adults. 
Non tender, discrete, mobile, firm lymph nodes are palpable. 
Upper anterior deep cervical nodes are enlarged. 
2- Stage of periadenitis 
Nodes are matted and move together. 
Firm and non-tender. 
  
Matting is pathognomonic of tuberculosis. 
3- Stage of cold abscess 
It occurs due to caseation necrosis of lymph nodes resulting in 
fluctuant swelling in the neck. The cold abcess are not warm, not 
tender, soft, cystic and fluctuant. Swelling is deep to deep fascia. 
4- Stage of collar stud abscess  
It results when a cold abcess which is deep to deep fascia ruptures 
through the deep fascia and forms another swelling in subcutaneous 
plane which is fluctuant. 
5- Stage of sinus 
It occurs when collar stud abcess ruptures through the skin. 
It may be multiple. Skin surrounding the sinus shows pigmentation 
and sometimes bluish in colour. 
Treatment for tuberculous lymphadenitis involves administration of 
anti-tubercular regimens. Surgery is seldom indicated if anti-tuberculous 
treatment is effective, although limited surgery in conjunction with 
effective chemotherapy is sometimes appropriate. The emergence of 
multi-resistant strains of tuberculosis, however, means that once again the 
  
surgeon may have to operate for this condition when no other treatment is 
effective. 
When surgery is undertaken for resistant disease, it must include 
the excision of all diseased nodes if it is to offer a reasonable chance of 
eradication of the infection, and healing. This can, however, be a 
challenging operation when the deep cervical nodes are matted and 
adherent to the internal jugular vein, the wall of which may form the 
medial wall of the tuberculous abscess. A dissection similar to the radical 
neck dissection may be necessary to secure the internal jugular vein 
above and below the segment of involved vein, which has to be removed 
en bloc with the specimen. The accessory nerve and the 
sternocleidomastoid muscle can usually be preserved. 
Cold abscess are drained non dependently. Tubercular sinuses are 
excised along with the tract. 
  
ULTRASONOGRAPHY 
Ultrasound has an important role in head and neck imaging. It is 
does not involve ionising radiation and inexpensive. Fine-needle 
aspiration cytology (FNAC) or core biopsy can be taken under ultrasound 
guidance. The superficial nature of the neck structures makes ultrasound 
assessment easy and reliable.  
  
Ultrasound differentiates pathological nodes (e.g., metastases, 
lymphoma, tuberculous lymphadenitis) from normal/reactive nodes. 
Certain criteria are laid down to differentiate benign from malignant 
nodes. Size of the node measured using minimum axial diameter is the 
most specific dimension for predicting malignancy. It is recommend a 
minimum axial diameter of 7 mm for submental/submandibular nodes 
and 8 mm for other cervical nodes. 
Benign nodes tend to have an elliptical shape, while malignant 
lymph nodes are rounded. In benign nodes hilus is echogenic, which 
indicates preserved sinusoidal architecture. In malignant nodes, the hilus 
is absent and they look round. 
An enlarged lymph node which is diffusely hypoechoic or 
pseudocystic is suggestive of lymphoma. 
Enlarged lymph nodes with metastatic squamous cell carcinoma 
deposits have coagulative and cystic necrosis. Cystic degeneration is also 
seen in tuberculous nodes and papillary thyroid carcinoma metastases. 
The lymph node metastases from papillary carcinoma have typical small 
punctate calcifications. The sign is specific and attempt is made to search 
for primary in thyroid. Ultrasound can show presence of an ill-defined 
  
border or frank invasion of neighbouring structures which in turn 
indicates poor prognosis.  
A colour Doppler can make out the distribution of vessels within a 
node. Benign nodes have a central hilar flow pattern, whereas malignant 
nodes have a disorganized peripheral pattern. Necrotic areas are relatively 
avascular. 
These signs aid to arrive at a specific diagnosis. It also helps 
choose the lymph node for ultrasound-guided FNAC. 
CT and MRI 
Three-dimensional and multiplanar modeling of the CT data can 
provide the surgeon with a better appreciation of the anatomy 
preoperatively, providing a more surgically oriented perspective of the 
pathology and, in some cases, allowing for production of synthetic 
prostheses to be prepared preoperatively to fit the patient’s anticipated 
surgical defect. With this information, the head and neck surgeon can 
have a more informed discussion with the patient regarding potential 
operative options and prognosis. Staging of nodal disease in the neck 
traditionally has been based on clinical examination; however, imaging 
can supplement clinical examination. CT and MRI, uses a threshold size 
to determine if a node is abnormal. Depending on the reference, this size 
  
varies between 1 and 1.5cm. Morphology of the node is also considered 
in determining the likelihood of metastasis, including the transverse-to-
longitudinal ratio and the attenuation of the node. 
Positron Emission Tomography 
Positron emission tomography (PET) is a functional nuclear 
medicine imaging technique. It is used to assess metabolic, biochemical, 
and physiologic parameters of disease.  
Cancer cells differ from normal cells in various biological 
processes like glucose consumption, amino acid synthesis, DNA 
synthesis, oxygenation, perfusion, cell membrane synthesis etc. When 
biological substances involved in these processes are tagged with 
radiotracers, their change in distribution and localisation in the body 
becomes valuable. The most commonly used PET radiotracer is 18F-2-
fluoro-2-deoxy-D-glucose (FDG), an analogue of endogenous glucose. 
Cancer cells have a high mitotic rate, hence their glucose requirement and 
uptake is high. 
 
In PET-CT, there is a combined evaluation of anatomical and 
metabolic picture of the imaged region. This proves extremely valuable 
for diagnosis, staging, estimation of therapeutic response, restaging, and 
evaluation of recurrence. They are also useful in guiding biopsy, 
  
predicting prognosis, and detecting the nature of indeterminate lesions 
found by other imaging methods.  
 
PET-CT imaging is very useful in patients with metastatic nodes in 
neck with unknown primary, when pan-endoscopy and other imaging 
methods fail to detect primary. Field cancerisation is seen in head and 
neck cancers. Detection of second primary is also possible with PET-CT 
imaging. 
With these benefits, whole-body PET and PET-CT imaging are 
frequently used in staging and restaging algorithms of head and neck 
cancers. 
 
Fine Needle Aspiration cytology 
Fine Needle Aspiration cytology (FNAC) is a procedure that 
involves passing a thin hollow needle through the tissue to be studied, to 
sample cells for microscopic analysis.  
Fine needle aspirations can be performed on palpable swellings or 
impalpable lesions which are image detected. For impalpable lesions, 
imaging is done to see the nature of the lesion and localize it. Then if 
aspiration is warranted, needle is passed under image guidance. Needle is 
  
ensured to be in the lesion before aspiration. Ultrasound is the most 
frequently used, but CT, PET-CT can also be used.  
FNAC can be done on an outpatient basis 
 The skin over the proposed site of aspiration is cleaned. Needle is 
passed into the swelling, aspirated, smeared and sent for analysis. The 
needle used for fine needle aspiration cytology has a gauge of 22 to 25 G. 
Multiple insertions and aspirations may be required to get adequate 
sample. The site of aspiration is covered with a small bandage. The 
patient can continue his normal activities post procedure. Usually there 
are no complications; but some patients may complain of pain, swelling, 
or bleeding at the prick site.  
Local anaesthesia is usually not required. Time required for the 
procedure is very less. 
Comparing FNAC to other modalities of tissue sampling it is 
 non-invasive 
 no anaesthesia 
 less painful  
 no scarring  
 shorter recovery time 
 minimal complications 
  
 quicker method 
 repeatable 
The risks of FNAC include the theoretic possibility of cancer cells 
being trailed into unaffected tissue as the needle is removed. FNAC 
samples only a small number of cells from a swelling, there is a risk of 
missing abnormal cells. This is very important in cystic neoplasms and 
micro metastatic nodes. Image guided FNAC reduces these errors.  
Skills required to perform a good FNAC are 
• Familiarity with general anatomy 
• Good knowledge in normal cellular elements from various organs  
and tissue and how they appear on smears  
• Comprehensive knowledge of surgical pathology 
• Ability to translate traditional tissue patterns of lesions to their 
appearance in smears 
o Adjuvant tools for better diagnosis  
• Cell blocks 
• Histochemistry 
• Immunohistochemistry 
• Electron microscopy 
  
• Flow cytometry 
• Immuno electron microscopy 
• Molecular pathology -In situ hybridization, PCR etc 
 
Diagnostic Lymph Node Biopsy 
Patient is positioned in supine position with head turned away from 
the side on which the biopsy is to be performed. The region of the 
proposed incision is infilterated with local anaesthesia. A transverse 
incision is made over the palpable node selected for biopsy. The incision 
is deepened through the platysma, retracting the sternocleidomastoid 
muscle to expose the node. Node is dissected intact with minimal trauma. 
As dissection progresses, the hilum of the lymph node containing a small 
artery and vein is identified. Hilum is clamped and ligated. 
If a matted group of nodes, extending much farther proximally and 
distally than previously expected, an adequate portion of the accessible 
surface of the mass is removed rather than attempting complete removal. 
In case of matted but still lobulated mass, attempt is made to shell out an 
entire node. Hemostasis achieved in the residual nodal mass by 
electrocautary or suture ligature. The incision is closed in layers with fine 
  
interrupted sutures. The lymph node specimen is sent fresh to the 
laboratory. 
Deeper nodes are excised in general anaesthesia and with a 
protected airway. Care is taken not to damage the internal jugular vein; if 
need be its anterior tributaries such as facial and thyroid veins, may have 
to be ligated and divided.  
 
Supraclavicular nodes are often deceptive, and found at operation 
to be deeper than initially suspected. They may merely be the only 
accessible part of a huge mass of matted mediastinal nodes, which are 
compressing the trachea and distorting the anatomy of the great vessels at 
the root of the neck. The surgeon should dissect with caution in optimum 
surgical and anaesthetic conditions. Tracheal compression in the superior 
mediastinum can make a general anaesthetic hazardous, but this is also a 
hazardous area for a surgeon to operate under local anaesthesia. 
 
NECK DISSECTIONS 
A neck dissection is an operation that is done for individuals with 
cancer of the head and neck to remove the lymph nodes in the neck. 
Classification of Neck Dissections 
  
Academy’s Committee for Head and Neck Surgery and Oncology 
publicized standard classification system in 1991 
 
Academy’s classification is based on 4 concepts 
1) RND is the standard basic procedure for cervical lymphadenectomy 
against which all other modifications are compared 
2) Modifications of the RND which include preservation of any non-
lymphatic structures are referred to as modified radical neck dissection 
(MRND) 
3) Any neck dissection that preserves one or more groups or levels of 
lymph nodes is referred to as a selective neck dissection (SND) 
4) An extended neck dissection refers to the removal of additional lymph 
node groups or non-lymphatic structures relative to the RND 
 
Academy’s classification 
1) Radical neck dissection (RND) 
2) Modified radical neck dissection (MRND) 
3) Selective neck dissection (SND) 
• Supra-omohyoid type 
• Lateral type 
• Posterolateral type 
• Anterior compartment type 
  
4) Extended radical neck dissection 
 
Radical Neck Dissection (RND) 
All lymph nodes in Levels I-V including spinal accessory nerve , 
sternocleidomastoid muscle, and internal jugular vein are excised. 
Indications 
Extensive cervical involvement or matted lymph nodes with gross 
extracapsular spread and invasion into the spinal accessory nerve, 
sternocleidomastoid muscle, or the internal jugular vein. 
 
Modified Radical Neck Dissection (MRND) 
Excision of same lymph node bearing regions as RND with 
preservation of one or more nonlymphatic structures (spinal accessory 
nerve, sternocleidomastoid muscle, internal jugular vein). 
MRND is analogous to the ―functional neck dissection‖ described by 
Bocca. 
Three types of Modified Radical Neck Dissection (Medina 1989) are 
commonly referred  
• Type I: Preservation of spinal accessory nerve 
• Type II: Preservation of spinal accessory nerve and internal jugular vein 
• Type III: Preservation of spinal accessory nerve, internal jugular vein, 
and sternocleidomastoid muscle. 
  
 
MRND Type I 
Indications 
– Clinically obvious lymph node metastases 
– Sternocleidomastoid muscle not involved by tumor 
– Intraoperative decision 
 
MRND Type II 
Indications 
– Rarely planned 
– Intraoperative tumor found adherent to the sternocleidomastoid, but 
not internal jugular vein and spinal accessory nerve 
 
MRND Type III 
– Widely accepted. 
– Neck dissection of choice for N0 neck 
 
Advantages of  Modified Radical Neck Dissection 
– Reduce postsurgical shoulder pain and shoulder dysfunction 
– Improve cosmetic outcome 
  
– Reduce likelihood of bilateral IJV resection in cases were contralateral 
neck is also involved. 
 
Selective Neck Dissections 
Selective Neck Dissection is cervical lymphadenectomy with 
preservation of one or more lymph node groups. Lymphatic spread from 
mucosal surfaces of the head and neck tumors have predictable routes. 
The rate of occult metastasis in clinically negative neck is 20-30%.  
 
Indications 
• Primary lesion with 20% or greater risk of occult metastasis 
• May elect to upgrade neck intraoperatively. 
• Frozen section is needed to confirm in suspicious node. 
• Need for post-op radiotherapy is high. 
 
– Four common subtypes: 
• Supraomohyoid neck dissection 
• Posterolateral neck dissection 
• Lateral neck dissection 
• Anterior neck dissection 
 
  
Supraomohyoid neck dissection 
Supraomohyoid neck dissection is the most commonly performed 
SND. Expectant management of oral carcinoma with N0 neck is not 
advocated. 
Oral cavity carcinomas rarely involve Level IV and V. 
With this rationale supraomohyoid neck dissection  involves en 
bloc removal of cervical lymph node groups I-III. The posterior limit is 
the cervical plexus and posterior border of the sternocleidomastoid. 
Inferior limit is the omohyoid muscle overlying the internal jugular vein. 
Indications 
Oral cavity carcinoma with N0 neck (T2-T4NO) 
Unknown primary with palpable node <3cm, mobile, and in levels I or II 
(TXN1) 
 
Adjuvant RT is given to patients with > 2- 4 positive nodes with or 
without extracapsular spread. 
 
Lateral neck dissection 
 Lateral neck dissection involves en bloc removal of the jugular lymph 
nodes including Levels II-IV. 
 
Indications 
  
N0 neck in carcinomas of the oropharynx, hypopharynx, supraglottis, and 
larynxas occult metastases is seen 30-35%. 
 
Bilateral dissection is often indicated in the majority of 
hypopharyngeal tumors because of extensive submucosal spread and 
involvement of multiple subsites. 
 
Posterolateral neck dissection 
Posterolateral neck dissection involves en bloc excision of lymph 
bearing tissues in Levels II-IV and additionally–suboccipital and 
postauricular node groups 
Indications 
– Cutaneous malignancies 
• Melanoma 
• Squamous cell carcinoma 
• Merkel cell carcinoma 
– Soft tissue sarcomas of the scalp and neck. 
 
Anterior Compartment neck dissection 
Anterior Compartment neck dissection  involves en bloc removal 
of lymph structures in Level VI 
• Perithyroidal nodes 
  
• Pretracheal nodes 
• Precricoid nodes (Delphian) 
• Paratracheal nodes along recurrent nerves 
The limits of the dissection are the hyoid bone, suprasternal notch and 
carotid sheaths. 
Indications 
– Selected cases of thyroid carcinoma 
– Parathyroid carcinoma 
– Subglottic carcinoma 
– Laryngeal carcinoma with subglottic extension 
– Carcinoma of the cervical oesophagus. 
 
Extended Neck Dissection 
Extended Neck Dissection is any dissection which includes 
removal of one or more additional lymph node groups and/or non-
lymphatic structures. 
It is usually performed with N+ necks in MRND or RND when 
metastases invade structures usually preserved. 
Indications 
– Carotid artery invasion 
– Other examples: 
• Resection of the hypoglossal nerve resection or digastric muscle 
  
• Dissection of mediastinal nodes and central compartment for 
subglottic involvement 
• Removal of retropharyngeal lymph nodes for tumors originating 
in the pharyngeal walls. 
 
NECK DISSECTION  
The incisions for any form of radical neck dissection must be 
planned to afford good access and to leave inconspicuous scars. In 
addition, skin viability must be preserved, as carotid artery exposed by 
skin breakdown has a risk of rupture. The blood supply of the skin of the 
lateral neck comes from all directions, with a resultant relatively poorly 
vascularized central area directly over the common carotid artery. 
Vertical incisions and three point junctions in this central area should 
therefore be avoided. 
The skin flaps are elevated to include the platysma. In the 
submandibular area, in order to preserve the marginal mandibular branch 
of the facial nerve, the nerve is formally identified. If this is difficult, the 
flaps should be elevated by dissection in a deeper plane. This plane is on 
the body of the submandibular gland and the fascia over the gland is 
included in the flap. 
 Inferiorly the sternal and clavicular heads of sternocleidomastoid 
are divided to expose the carotid sheath. The internal jugular vein is 
  
isolated by dissection around it, and the vagus nerve, lying in a deep 
plane between the vein and the common carotid artery, is identified and 
preserved. The vein is then divided between ligatures. On the left, the 
thoracic duct is commonly divided at this point and will require 
oversewing to prevent leakage. The dissection is continued laterally, 
above the prevertebral fascia, to the anterior border of trapezius, elevating 
the fat pad overlying the scalene muscles and dividing the inferior belly 
of the omohyoid muscle which is included in the specimen. The external 
jugular vein and supraclavicular cutaneous nerves must also be divided. 
The transverse cervical vessels lie between the fat pad and the 
prevertebral fascia and should, if possible, be preserved. Underneath the 
prevertebral fascia the phrenic nerve runs medially and downwards on 
scalenus anterior. It is identified and preserved. The trunks of the brachial 
plexus are also beneath this fascia. 
Posteriorly the limit of dissection is trapezius, and the dissection is 
continued up along its anterior border. The transverse cervical artery 
gives a vertical branch which runs up the anterior border of trapezius and 
requires formal ligation and division. The accessory nerve is divided in 
the classical radical dissection as it enters the muscle, but is preserved in 
all modified neck dissections. The upper third of the trapezius approaches 
the posterior border of the sternocleidomastoid muscle, the fibres of 
which are divided close to their mastoid insertion. 
  
Anteriorly the superior belly of the omohyoid muscle forms the 
boundary of the dissection and is followed to its insertion into the hyoid 
bone and divided. The submental fat pad is dissected off until the anterior 
bellies of both digastric muscles are identified. 
The deep dissection is commenced by reflecting forwards the 
posterior margin of the dissection and releasing the fat pad, with the 
nodes, off the prevertebral fascia and the underlying muscles, the levator 
scapulae and the scalenes. It is tethered down by the three cutaneous 
branches of the cervical plexus, namely the anterior cutaneous nerve of 
the neck, the great auricular nerve and the lesser occipital nerve. These 
nerves are identified and divided well away from the phrenic nerve. The 
internal jugular vein is dissected out of the carotid sheath up to the 
jugular foramen. The transverse process of the atlas is palpated and, just 
above this, the posterior belly of digastric will be found.This is retracted 
upwards, and the upper end of the jugular vein exposed where it is again 
divided between ligatures, with care being taken to preserve the vagus 
nerve. The hypoglossal nerve can be seen crossing lateral to the external 
carotid artery, and is in turn crossed by three small veins draining from 
the tissue to be excised. These vessels must be ligated and divided or they 
will tear, and attempts to stop the bleeding will endanger the hypoglossal 
nerve. The remaining sternocleidomastoid fibres are divided at the level 
of a line extending from the tip of the mastoid process to the angle of the 
  
jaw. A higher division places the facial nerve at risk, as it lies deep to the 
anterior border of the muscle. 
Superiorly the submental fat pad, and the anterior edge of the 
submandibular gland, are dissected off the lateral surface of the 
mylohyoid muscle. The submental artery will require ligation and 
division. The posterior edge of mylohyoid is then retracted forwards, and 
the gland retracted inferiorly, to expose the lingual nerve which is freed 
and preserved. The submandibular duct is ligated. The facial vessels are 
ligated at the upper border of the gland, and the facial artery again at the 
inferior border. 
 
COMPLICATIONS 
Immediate complications include haemorrhage and pneumothorax, 
and raised intracranial pressure from compromised venous drainage. 
Necrosis of skin flaps, with exposure of the carotid artery, is a serious 
intermediate-term complication which requires further surgery at the 
earliest opportunity to cover the vulnerable vessel. A chylous fistula from 
injury to the thoracic duct is initially treated conservatively but 
occasionally may require surgical intervention. Late complications 
include a frozen shoulder, in addition to the inevitable loss of function if 
the accessory nerve has been sacrificed. 
 
  
IV – MATERIALS AND METHODS 
 The study was conducted on 100 selected patients with cervical 
lymphadenopathy who presented to the General Surgical Department 
with cervical lymphadenopathy. Patients’ informed written consent was 
taken. The patients were examined clinically after taking a detailed 
history. Nodes enlarged were classified according to Memorial Sloan-
Kettering Cancer Centre leveling system of cervical lymph nodes. The 
number of nodes, their size, consistency and presence of periadenitis was 
noted at each level. Histories of any form of previous treatment to the 
nodes like radiotherapy, chemotherapy were excluded from the study. 
Terminally ill patients were also excluded. 
Blood investigations and radiological investigations were made. 
Ultrasonography of the neck and CT scan were made wherever necessary. 
A pre FNAC clinical diagnosis was arrived. Patients requiring surgical 
biopsy either in the form of node biopsy or neck dissection were included 
in study. 
A Fine Needle Aspiration Cytology was done.  
The equipments used for FNAC  
1. Spirit soaked cotton swab 
2. 10 ml disposable syringe 
3. 22 G disposable needle 
4. 5 Glass slides 
  
5. Jar with ether-alcohol fixative 
 
PROCEDURE 
Patient was made to lie on a table. The node was localized and skin 
prepared with a spirit swab. No local anaesthesia was used. About 5 ml of 
air was aspirated into the syringe before the introduction of the needle 
into the mass which was held between the finger and thumb of the other 
hand. This is to obtain a uniform distribution of aspiration material on the 
glass slide. The needle was introduced into the node. Once the node was 
entered the syringe was pulled to full suction and the needle advanced 3 
to 5 times to various foci within the node. With the continued suction, till 
fluid or cellular material was seen to enter the hub of the needle. Care 
was taken to ensure that the material was not aspirated into the syringe. 
Thereafter the plunger was released and the fall in suction allows it to 
return to the 5ml mark. This prevents the forceful dispersion of the 
aspirate into the cylinder of the syringe while the needle is being 
withdrawn. Following removal of the aspirated needle, gentle pressure 
was applied to the aspirated site for 1 – 2 minutes to prevent hematoma 
formation. 
The needle contents were then expressed to glass slides by 
touching the needle to surface to prevent air-drying and a smear was 
made in a manner similar to that for a blood film. At least 5 smears were 
  
made, one was air dried and the others were immediately placed in the 
ether-alcohol fixative. The smears were stained with Eosin-Hematoxylin. 
Hypocellular slides were excluded from the study. A repeat FNAC 
was allowed. The cytopathologist was final in deciding adequacy of yield 
of FNAC. Ultrasound guided FNAC was done were ever necessary to get 
adequate yield. 
Patient was subjected to excision biopsy from the same node in 
cases with diagnosis of non-metastatic nodes. Patients diagnosed of 
secondaries in the nodes were subjected to appropriate composite 
resection with neck dissection. 
Post-surgical excision the same node was subjected to 
histopathological examination.  
The cytopathological diagnoses were compared with the 
histopathological results of the same excised nodes. Diagnostic 
sensitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV) was calculated. 
 
V – RESULTS AND ANALYSIS 
A total of 100 patients were examined, subjected to FNAC of 
cervical lymph nodes and histopathological study. Patients with acute 
presentation of lymphadenopathy and diagnosed as non-specific 
lymphadenitis with or without FNAC correlation were excluded from 
  
study. They were treated with antibiotics and followed up in the 
outpatient department. The size of the nodes, which were, sampled range 
from 1 – 6 cm. No complication due to cytology occurred in the series. 
All inadequate and inconclusive aspirations were repeated. 
 METASTATIC LYMPHADENOPATHY 
 
Of the 59 patients who had a known primary, 58 patients had nodal 
metastasis in their exact nodal levels. Only one patient with carcinoma of 
tongue had skip metastasis. Level 2 nodes were the most common nodes 
involved.  
FNAC done on 60 patients with metastatic nodes, all the cases 
showed positivity. The diagnostic accuracy was 100%. The type was not 
specified in 6 smears and only a diagnosis of positive for malignant cells 
was given. There was one case of papillary carcinoma of thyroid were 
aspirate was cystic, which on further aspiration with ultrasound guidance 
was positive. 
 
LYMPHOMA 
 
There was no definitive nodal pattern of involvement. 
Of the 12 cases of lymphoma confirmed by histopathology, 11 
cases were reported lymphoma. Of this 6 cases were just reported as 
lymphoproliferative disorder needing further biopsy correlation.  
The overall diagnostic accuracy was 91% 
  
 
TUBERCULOSIS 
 
Of the 18 cases identified by histopathology correlation with 
FNAC was obtained in 16 cases. The diagnostic accuracy was 88%. In 2 
cases a non-specific diagnosis of granulomatous adenitis was reported. 
Among the false negatives where a clinical suspicion was entertained 
(supplemented with positive Mantoux and history of exposure), two were 
reported as chronic non-specific adenitis.  
REACTIVE NODES 
Another 10 patients who had chronic lymphadenitis, cytologically 
reported as reactive nodes were subjected to biopsy and the study 
correlated in all of them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 FNAC RESULT IN CERVICAL LYMPHADENITIS 
 
 
 DISEASE  Positive DISEASE Negative 
FNAC positive 87 0 
FNAC negative 3 10 
 
Specificity – 100% 
Sensitivity- 96.66% 
Positive Predictive Value – 100% 
Negative Predictive Value – 76.92% 
 
Overall, FNAC had a very high specificity and positive predictive value. 
A positive FNAC is very significant. A negative FNAC may not rule out 
the disease. 
 
  
 
Incidence of Metastatic Primary 
Cheek 22 
Tongue 14 
Alveolus 4 
Thyroid 6 
Parotid 4 
Lip 1 
Maxilla 3 
Soft Palate 1 
Floor Of Mouth 1 
Retromolar trigone 2 
Supraglottis 1 
Unknown 1 
TOTAL 60 
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Incidence of Metastatic Nodes 
Level 1 43 
Level 2 57 
Level 3 36 
Level 4 15 
Level 5 5 
Level 6 2 
Level 7 1 
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Gender Distribution of Metastatic Nodes 
Male Female
Gender Distribution of Metastatic 
Nodes 
Male 41 
Female 19 
  
 
 
 
 
Age Distribution of Metastatic Nodes 
0-9 - 
10 - 19y 1 
20-29 3 
30- 39 12 
40-49 14 
50-59 15 
60-69 10 
70-79 5 
TOTAL 60 
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Incidence of Lymphoma 
Hodkins 5 
Nonhodkins 7 
 
 
Gender 
Male 9 
Female 3 
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Incidence of Nodes in 
Lymphoma 
Level 1 - 
Level 2 4 
Level 3 6 
Level 4 7 
Level 5 12 
Level 6 3 
Level 7 1 
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Age Distribution of Lymphoma 
0-9 1 
10 - 19y 2 
20-29 3 
30- 39 1 
40-49 1 
50-59 2 
60-69 1 
70-79 1 
Total 12 
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Gender 
Male 12 
Female 6 
 
 
 
 
 
 
 
 
Gender Distribution of Tuberculous Nodes 
Male Female
  
 
 
 
 
 
 
Incidence of  Tuberculous Nodes 
Level 1 2 
Level 2 6 
Level 3 9 
Level 4 11 
Level 5 13 
Level 6 - 
Level 7 - 
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Age Distribution of Tuberculous 
Nodes 
0-9 - 
10 - 19y 3 
20-29 2 
30- 39 4 
40-49 5 
50-59 1 
60-69 2 
70-79 1 
Total 18 
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Gender Distribution of 
Nonspecific Lymphadenitis 
 
Male 7 
Female 3 
 
 
 
 
 
Gender Distribution of Nonspecific 
Lymphadenitis 
Male Female
  
 
 
 
 
 
Incidence of  Nonspecific 
Lymphadenitis 
Level 1 2 
Level 2 2 
Level 3 5 
Level 4 5 
Level 5 7 
Level 6 - 
Level 7 - 
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Age Distribution of Nonspecific 
Lymphadenitis 
0-9 - 
10 - 19y 4 
20-29 3 
30- 39 1 
40-49 - 
50-59 - 
60-69 2 
70-79 - 
Total 10 
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FNAC RESULT IN METASTATIC 
LYMPHADENOPATHY 
 
 
FNAC positive Histopathology positive 
60 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
METASTATIC NODES 
Positive
False Negative
  
 
FNAC RESULT IN LYMPHOMA 
 
 
 
FNAC positive Histopathology positive 
11 12 
 
 
 
 
 
 
 
 
 
 
 
LYMPHOMA 
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FNAC RESULT IN TUBERCULOSIS 
 
 
 
 
 
FNAC positive Histopathology positive 
16 18 
 
 
 
 
 
 
 
 
TUBERCULOSIS 
Positive
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FNAC RESULT IN NONSPECIFIC LYMPHADENITIS 
 
 
 
FNAC positive Histopathology positive 
10 10 
 
 
 
 
 
 
 
NONSPECIFIC LYMPHADENITIS 
Positive
False Negative
  
VI – CONCLUSION 
Cervical lymphadenopathy can be due to varying causes. The 
diagnosis of which involves clinical examination, imaging and 
pathological correlation. The fact that secondaries from head and neck 
primary, follows definitive patterns of nodal spread proves very valuable.  
Cytology forms one of the most important investigations in the 
initial evaluation of cervical lymphadenopathy. Early confirmation of the 
disease facilitates institution of immediate treatment. In case of 
discordance between clinical and cytological findings, FNAC is always 
repeatable. Further a positive cytology is always significant. A negative 
result does not rule out the disease and may require further evaluation. A 
good cytological study requires a good communication between an 
experienced cytologist and treating surgeon. This study demonstrates that 
fine needle aspiration is a safe, accurate and valuable tool in the 
evaluation of cervical lymphadenopathy. It helps in planning surgery for 
malignant cases, where definitive operative intervention can be performed 
in one session. It permits early institution of anti-tubercular drugs in 
patients with tuberculous lymphadenitis.  In case of undetected primary 
tumour, FNAC directs further investigations towards the possible 
primary. 
The two fundamental requirements on which the success of 
cytology depends are representativeness of the sample and high quality of 
  
the preparation. The main advantage of FNAC lies in its simplicity. Being 
an uncomplicated outpatient procedure that offers a rapid and specific 
diagnosis with little trauma, it is very cost-effective. It is ideal for 
developing countries and smaller hospitals with limited resources. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
FNAC Slides 
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PROFORMA 
Role of cytological evaluation in cervical lymphadenopathy 
Name       Diagnosis 
Age/Sex                                                                          Date:     
Op/Ip No 
HISTORY 
Duration 
Examination 
Nodes enlarged: 
RIGHT LEFT 
Levels Size Number Consistency Periadenitis Levels Size Number Consistency Periadenitis 
 I      I     
II  
A/B 
    II  
A/B 
    
III     III     
IV     IV     
V 
A/B 
    V 
A/B 
    
VI     VI     
Previous treatment:       
OTHERS 
INVESTIGATIONS 
CBC        
X ray        
SPL INV 
USG 
CT neck        Other CT
  
Informed consent 
Pre FNAC DIAGNOSIS:        
 Date. 
FNAC material yield :  
FNAC REPORT: 
 
 
 
 
 
 
 
 
 
 
 
 
Repeat FNAC 
SURGERY: 
HPE: 
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MASTER CHART 
Sl 
no. 
Name Age SEX IP No Primary Clinical FNAC Histopathology 
1 Krishna Kumar 36 M 91806 Tongue L1,2 SCC SCC 
2 Perumal 60 M 91849 Cheek L1,2 SCC SCC 
3 Janaki 33 F 91799 Parotid L2,3 Mucoepidermoid Ca Mucoepidermoid Ca 
4 Janani 17 F 92731 Pap Thyroid L2,3,4 PAP Ca PAP Ca 
5 Sangothy 60 F 71496 Cheek L1 SCC SCC 
6 Govindaswamy 70 M 84646 Tongue L1,2,3 SCC SCC 
7 Jainullabudin 72 M 91745 Tongue L2,3 SCC SCC 
8 Suguna 42 F 96803 Cheek L1,2 SCC SCC 
9 Sathyasheelan 56 M 100617 Cheek L1,2 SCC SCC 
10 James 32 M 100281 Cheek L1,2,3,4 SCC SCC 
11 Samyayya 56 M 101399 Maxilla L1,2 SCC SCC 
12 Saravannan 33 M 105404 Cheek L1,2 SCC SCC 
13 Sunderraj 31 M 1855 Cheek L1,2,3 SCC SCC 
14 Shanmugam 75 M 105978 Pap Thyroid L2,3,4,6,7 PAP Ca PAP Ca 
15 Gomathy 38 F 3457 Maxilla L2,3 Adenocystic Ca Adenocystic Ca 
16 Thangamani 58 M 116716 Retromolar 
trigone 
L2,3,4,5 SCC SCC 
17 Madhavan 50 M 3938 Tongue L1,2,3 SCC SCC 
18 Kandaswamy 23 M 5357 Soft Palate L2,3 SCC SCC 
  
19 Mani 50 M 5256 Cheek L1,2 SCC SCC 
20 Jayammal 70 F 6130 Cheek L1,2,3 SCC SCC 
21 Dhanam 70 F 10234 Cheek L1,2 SCC SCC 
22 Prabhu 48 M 15040 Cheek L1 SCC SCC 
23 Sivakumar 43 M 3915 Tongue L1,2,3 SCC SCC 
24 Penchilammal 45 F 13334 Cheek L1,2 SCC SCC 
25 Arivazhagan 42 M 6895 Cheek L1,2 SCC SCC 
26 Irudhayamary 50 F 19749 Retromolar 
trigone 
L1,2,3,5 SCC SCC 
27 Manarswamy 65 M 12615 Lower Lip L1,2,3 SCC SCC 
28 Kaliyaperumal 53 M 18209 Parotid L2,3,5 Mucoepidermoid Mucoepidermoid 
29 Kannan 36 M 17571 Parotid L2 Mucoepidermoid  Mucoepidermoid 
30 Rajavel 48 M 19740 Cheek L1,2,3,4 SCC SCC 
31 Zahir Hussain 31 M 25283 Tongue L1,2 SCC SCC 
32 Sagayaraj 45 M 20415 Tongue L1 SCC SCC 
33 Shyamala 48 F 29117 Tongue L2,3 SCC SCC 
34 Samsudeen 62 M 17526 Thyroid L2,3,4 PAP Ca PAP Ca 
35 Somasundaram 55 M 52311 Maxilla L1,2,3 SCC SCC 
36 Muniammal 65 F 46057 Cheek L1,2 SCC SCC 
37 Ramaminthammal 40 F 46090 Cheek L1,2 SCC SCC 
38 Chandra 45 F 54640 Alveolus L1,2,3 SCC SCC 
39 Mohan 50 M 60160 Supraglottis L2,3,4 SCC SCC 
40 Vapu 64 M 61732 Unknown L 2,3 SCC SCC 
  
41 Saddique Basha 32 M 62533 Tongue L1,2 SCC SCC 
42 Sathyashelan 56 M 60164 Cheek L1,2 SCC SCC 
43 Vedhachalam 49 M 69817 Cheek L1,2 SCC SCC 
44 Thiruvenkatam 65 M 67347 Parotid L2,3,4 Mucoepidermoid Mucoepidermoid 
45 Antony 50 M 76960 Cheek L1,2,3 SCC SCC 
46 Maria 65 M 78226 Thyroid L2,3,4 PAP Ca PAP Ca 
47 Saroja 45 F 83465 Cheek L1,2 SCC SCC 
48 Kanagammal 57 M 84208 Tongue L1,2,3 SCC SCC 
49 Sankar Narayanan 22 M 86623 Thyroid L2,3,4,6 PAP Ca PAP Ca 
50 Kamalakannan 33 M 89090 Tongue L1,2 SCC SCC 
51 Gobinath 32 M 85353 Tongue L1,2,3 SCC SCC 
52 Kanaga 55 F 86665 Cheek L1,2 SCC SCC 
53 Vittabai 65 F 86670 Cheek L1,2 SCC SCC 
54 Kesavan 40 M 85783 Alveolus L1,2,3 SCC SCC 
55 Lakshmi 45 F 75307 Cheek L1,2 SCC SCC 
56 Loganathan 58 M 99400 Floor Of Mouth L1,2,3,4 SCC SCC 
57 Thanikachalam 65 M 104092 Lower Alveolus L1,2,3 SCC SCC 
58 Rafiq Khan 38 M 103074 Tongue L1,2,3 SCC SCC 
59 Sunitha 27 F 7950 Pap Thyroid L3,4 PAP Ca PAP Ca 
60 Ramani 53 F 78641 Tongue L1,2,3 SCC SCC 
61 Rani 57 F 5552 NHL L3,4,5 NHL NHL 
62 Murugan 45 M 76643 NHL L2,3,5 Reactive NHL 
63 Kannan 75 M 63475 NHL L3,4,5 NHL NHL 
  
64 Vignesh 9 M 100457 HL L4,5 HL HL 
65 Ajith Kumar 15 M 232626 NHL L2,5 NHL NHL 
66 Samikannu 50 M 98039 HL L4,5,6,7 HL HL 
67 Jayaseelan 19 M 95466 HL L4,5 HL HL 
68 Pugazhendi 23 M 2005 HL L3,5 HL HL 
69 Vanitha 37 F 74085 NHL L2,3,5 NHL NHL 
70 Suryakala 25 M 54499 HL L4,5,6 HL HL 
71 Prema 60 F 92979 NHL L4,5,6 NHL NHL 
72 Suresh 27 M 120182 NHL L2,3,5 NHL NHL 
73 Mahesh 18 M 13271 TB lymphadenitis L5 TB TB 
74 Devaraj 41 M 69895 TB lymphadenitis L4,5 TB TB 
75 Jeganathan 19 M 87518 TB lymphadenitis L5 TB TB 
76 Kumar 35 M 3681 TB lymphadenitis L3,4,5 TB TB 
77 Malathy 30 F 203004 TB lymphadenitis L1,2,3 TB TB 
78 Padma 60 F 6538 TB lymphadenitis L2,3,4,5 TB TB 
79 Seetharamaman 75 M 50599 TB lymphadenitis L2,3 TB TB 
80 Karumbairam 46 M 103920 TB lymphadenitis L4,5 TB TB 
81 Snehapriya 16 F 171388 TB lymphadenitis L5 TB TB 
82 Parthasarathy 30 M 4699 TB lymphadenitis L3,4,5 Reactive TB 
83 Karthickdas 50 M 89397 TB lymphadenitis L2,3,4 TB TB 
84 Vadivel 67 M 56494 TB lymphadenitis L3,4,5 TB TB 
85 Dhanalakshmi 32 F 10903 TB lymphadenitis L5 TB TB 
86 Nagalakshmi 48 F 37789 TB lymphadenitis L4,5 TB TB 
  
87 Mohanavel 45 M 48985 TB lymphadenitis L4,5 TB TB 
88 Amudha 42 F 31184 TB lymphadenitis L2,3,4 Reactive TB 
89 Jagadesan 22 M 25449 TB lymphadenitis L1,2,3 TB TB 
90 Giri 26 M 67138 TB lymphadenitis L4,5 TB TB 
91 Santha 64 F 64571 Non specific L5 Reactive Reactive 
92 Kavitha 24 F 61201 Non specific L5 Reactive Reactive 
93 Srinivas 25 M 95788 Non specific L3,4,5 Reactive Reactive 
94 Jayashree 13 F 98225 Non specific L4,5 Reactive Reactive 
95 Munivel 25 M 16722 Non specific L1,2,3 Reactive Reactive 
96 Kuppan 62 M 2805 Non specific L3,4 Reactive Reactive 
97 Shaukat Ali 38 M 2181 Non specific L3,4,5 Reactive  Reactive  
98 Ajith 15 M 115914 Non specific L1,5 Reactive Reactive 
99 Harikrishnan 13 M 29422 Non specific L2,5 Reactive  Reactive  
100 Gokul 14 M 105811 Non specific L3,4 Reactive Reactive 
 
 
